Wall Street on Friday ended a listless day with marginal losses, with the session echoing the overall movement seen this week ...

Eli Lilly is aware of this fact, which helps explain why it acquired Adverum Biotechnologies in late 2025 and just agreed to ...

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts ...

Although the stock is trading at a premium valuation, the company’s outstanding operational performance, strong financial ...

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit ...

For the quarter ended December 31, 2025, the SMA outperformed the Index on both a gross- and net-of-fees basis due to ...

GOOGL’s encore for that record peak of $340.49 on Wednesday was three-straight losses to end the week with only a 0.4% gain ...

Stock futures pointed higher Thursday as tech shares surged on record earnings from AI chipmaking giant TSMC, while oil prices sank as President Donald Trump dialed down the threat of a U.S. military ...

Warren Buffett is the world’s most famous, and maybe best, investor so I’m turning to him for some advice. I sweated enough ...

Alumis, Aktis Oncology, and W.R. Berkley saw significant insider buying last week. There were a handful of other notable ...

Welcome back! I’m dusting off my snow boots as I prepare to head to the World Economic Forum in Davos. Let me know what - if ...

During 2025, Mairs & Power Balanced Fund underperformed its benchmark by 6.91% due to equity underperformance. Read more here ...